Symptomatic treatment of nephrotic syndrome.
McLigeyo
S O
SO
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D004044:Dietary Proteins / Q000008:administration & dosage*; D006801:Humans; D009404:Nephrotic Syndrome / Q000628:therapy*
D000806:Angiotensin-Converting Enzyme Inhibitors; D000894:Anti-Inflammatory Agents, Non-Steroidal; D004044:Dietary Proteins